Everand Logo

Welcome to Everand!

  • STAT

    Trump administration unveils drug strategy document after lengthy delay

    Two years in the making, the Trump administration has unveiled its National Drug Control Strategy, a typically annual report outlining the government’s plan to police illegal drugs, reduce drug demand,…
    by Lev Facher Jan 31, 2019 2 minutes
    President Donald Trump speaks during an East Room event at the White House.

    WASHINGTON — The Trump administration on Thursday unveiled a strategic planning document two years in the making: the National Drug Control Strategy, traditionally a wide-ranging annual report that outlines the government’s approach to policing illegal drugs, reducing drug demand, and treating addiction.

    Though President Trump pledged to make the opioid crisis a top priority

    You’re reading a preview, subscribe to read more.

    More from STAT

    STAT2 min read
    STAT+: Pharmalittle: We’re Reading About Lilly’s Zepbound For Sleep Apnea, The FDA Budget, And More
    Eli Lilly reported positive results for Zepbound in obstructive sleep apnea, giving the medication a new edge in the highly competitive obesity market.
    STAT2 min read
    STAT+: Pharmalittle: We’re Reading About An Amgen Obesity Drug, A Senate Bill On Shortages, And More
    Amgen will no longer develop an early-stage obesity pill, and will instead focus on a more advanced injectable candidate to compete with Wegovy and Zepbound.
    STAT2 min read
    STAT+: Pharmalittle: We’re Reading About A Senate Probe Into Novo Pricing, A New UTI Antibiotic, And More
    The U.S. Senate health committee is investigating the prices Novo Nordisk charges for its blockbuster medications Ozempic and Wegovy.

    Related Books & Audiobooks